跳至主要内容
临床试验/CTRI/2024/05/067912
CTRI/2024/05/067912尚未招募3 期

Effect of Enteral Insulin on Time to Reach Full Enteral Feeding in Preterm Infants ≤ 32 weeks and ≤ 1250 grams: A Randomised Controlled Trial

Dr Neelam Kler1 个研究点 分布在 1 个国家目标入组 116 人开始时间: 2024年6月4日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
116
试验地点
1
主要终点
Time to reach full enteral feeding defined as total enteral intake of 180 ml/kg/day tolerated for 48 hours

研究概览

简要总结

This is a randomised controlled trial to study the effect of enteral insulin on time to reach full enteral feeding in preterm infants ≤ 32 weeks and ≤ 1250 grams. Preterm infants have an immature gut, reduced digestive capacity and poor intestinal motility. This leads to an increase in the time to reach full enteral feeding, thereby increasing the duration of parenteral nutrition, length of hospital stay and risk of sepsis. insulin present in breast milk is known to have a beneficial influence on maturation of gut. Insulin when supplemented orally, has a local effect on gut mucosa and helps in enterocyte proliferation, increased enzyme activity and improved absoprtive capacity of gut. Two randomised controlled trials on enteral insulin have reported benefits in terms of decreased time to reach full enteral feeding, improved feeding tolerance and decrease in duration of parenteral nutrition. These benefits could further translate in reduction in rates of sepsis and other PN associated complications. this can have important implications in the developing countries where this strategy has not been studied. we plan to conduct a randomised controlled trial to study the effect of enteral insulin on time to reach full enteral feeding in preterm infants ≤ 32 weeks gestation and ≤ 1250 gram birth weight. eligible infants will be randomly allocated into two groups, Group A (enteral insulin group) and group B (placebo group). we hypothesize that enteral insulin therapy compared to placebo will decrease time to reach full enteral feeding in preterm infants ≤ 32 weeks gestation and ≤ 1250 gram birth weight by 2.5 days. Our primary objective is to compare the time to reach full enteral feeding defined as feeding volume of 180 ml/kg/day tolerated for 48 hours, in enteral versus placebo group. Our secondary objectives are time to reach enteral intake of 100ml/kg/day, duration of parenteral nutrition, episodes of feeding intolerance, time taken to regain birth weight, incidence of culture positive sepsis, incidence of necrotising enterocolitis, episodes of hypoglycemia, growth velocity at stoppage of intervention and at discharge for weight, length and head circumference, duration of hospital stay and all cause mortality

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Investigator Blinded

入排标准

年龄范围
1.00 Day(s) 至 60.00 Day(s)(—)
性别
All

入选标准

  • preterm infants ≤ 32 weeks of gestation and ≤ 1250 gram in whom enteral feed is being initiated.

排除标准

  • gestational age less than 26 weeks or birth weight less than 500 gram suspected GI malformations maternal diabetes hypoglycemia requiring glucose administration of more than 12mg/kg/min in first 72 hours of life failure to obtain consent.

结局指标

主要结局

Time to reach full enteral feeding defined as total enteral intake of 180 ml/kg/day tolerated for 48 hours

时间窗: Day of life when baby reaches feeds to 180 ml/kg/day which baby has tolerated for 48 hours

次要结局

  • Time taken to reach enteral intake of 100 ml/kg/day tolerated for 48 hours(Duration of parenteral nutrition)

研究者

发起方
Dr Neelam Kler
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Neelam Kler

Sir Gangaram Hospital, NewDelhi

研究点 (1)

Loading locations...

相似试验